Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Schiff

Showing results (111-120 of 199) with videos related to

Pageof 20
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 23, 2014
Sub-100nm gold nanomatryoshkas improve photo-thermal therapy efficacy in large and highly aggressive triple negative breast tumorsCiceron Ayala-Orozco, Cordula Urban, Sandra Bishnoi, et al.
Breast Cancer Research and Treatment|May 12, 2012
SGK3 is associated with estrogen receptor expression in breast cancerJun Xu, Ma Wan, Quanyuan He, et al.
NPJ Breast Cancer|February 12, 2026
JAK/STAT1-interferon-ISGylation networks in breast cancer resistance to inhibitors of FOXM1 and CDK4/6Yvonne Ziegler, Sandeep Kumar, Carlos M Saeh, et al.
Breast Cancer Research : BCR|September 3, 2011
β1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinibCatherine Huang, Catherine C Park, Susan G Hilsenbeck, et al.
Nature Communications|October 4, 2016
Comprehensive functional analysis of the tousled-like kinase 2 frequently amplified in aggressive luminal breast cancersJin-Ah Kim, Ying Tan, Xian Wang, et al.
Nano Letters|November 25, 2010
Tracking of multimodal therapeutic nanocomplexes targeting breast cancer in vivoRizia Bardhan, Wenxue Chen, Marc Bartels, et al.
The Journal of Biological Chemistry|November 3, 2010
A noncompetitive small molecule inhibitor of estrogen-regulated gene expression and breast cancer cell growth that enhances proteasome-dependent degradation of estrogen receptor {alpha}Nicole M Kretzer, Milu T Cherian, Chengjian Mao, et al.
Scientific Reports|February 5, 2022
NPY1R exerts inhibitory action on estradiol-stimulated growth and predicts endocrine sensitivity and better survival in ER-positive breast cancerRaksha Bhat, Hariprasad Thangavel, Noor Mazin Abdulkareem, et al.
Oncogene|October 26, 2002
Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growthYongmin Liu, John Ludes-Meyers, Yun Zhang, et al.
Journal of the National Cancer Institute|March 6, 2003
Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancerC Kent Osborne, Valerie Bardou, Torsten A Hopp, et al.
Pageof 20

Showing results (111-120 of 199) with videos related to

Sort By:
Pageof 20
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 23, 2014
Sub-100nm gold nanomatryoshkas improve photo-thermal therapy efficacy in large and highly aggressive triple negative breast tumorsCiceron Ayala-Orozco, Cordula Urban, Sandra Bishnoi, et al.
Breast Cancer Research and Treatment|May 12, 2012
SGK3 is associated with estrogen receptor expression in breast cancerJun Xu, Ma Wan, Quanyuan He, et al.
NPJ Breast Cancer|February 12, 2026
JAK/STAT1-interferon-ISGylation networks in breast cancer resistance to inhibitors of FOXM1 and CDK4/6Yvonne Ziegler, Sandeep Kumar, Carlos M Saeh, et al.
Breast Cancer Research : BCR|September 3, 2011
β1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinibCatherine Huang, Catherine C Park, Susan G Hilsenbeck, et al.
Nature Communications|October 4, 2016
Comprehensive functional analysis of the tousled-like kinase 2 frequently amplified in aggressive luminal breast cancersJin-Ah Kim, Ying Tan, Xian Wang, et al.
Nano Letters|November 25, 2010
Tracking of multimodal therapeutic nanocomplexes targeting breast cancer in vivoRizia Bardhan, Wenxue Chen, Marc Bartels, et al.
The Journal of Biological Chemistry|November 3, 2010
A noncompetitive small molecule inhibitor of estrogen-regulated gene expression and breast cancer cell growth that enhances proteasome-dependent degradation of estrogen receptor {alpha}Nicole M Kretzer, Milu T Cherian, Chengjian Mao, et al.
Scientific Reports|February 5, 2022
NPY1R exerts inhibitory action on estradiol-stimulated growth and predicts endocrine sensitivity and better survival in ER-positive breast cancerRaksha Bhat, Hariprasad Thangavel, Noor Mazin Abdulkareem, et al.
Oncogene|October 26, 2002
Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growthYongmin Liu, John Ludes-Meyers, Yun Zhang, et al.
Journal of the National Cancer Institute|March 6, 2003
Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancerC Kent Osborne, Valerie Bardou, Torsten A Hopp, et al.
Pageof 20